The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcome of primary mediastinal large B-cell lymphoma (PMBCL) in the pre- and post-rituximab era: The Stanford University experience.
L. S. Maeda
No relevant relationships to disclose
R. T. Hoppe
No relevant relationships to disclose
R. R. Balise
No relevant relationships to disclose
S. A. Rosenberg
No relevant relationships to disclose
S. J. Horning
No relevant relationships to disclose
R. Advani
No relevant relationships to disclose